Track topics on Twitter Track topics that are important to you
Novo Nordisk confirmed today it will eliminate 250 U.S. jobs in business functions—the company’s second set of workforce reductions worldwide in as many weeks. Of the planned job cuts, 100 are back-office positions based at Novo Nordisk’s U.S. headquarters in Princeton, NJ, while the other 150 are diabetes treatment support positions. The 250 job cuts come 10 days after Novo Nordisk said it will eliminate 400 R&D employees in its headquarters country of Denmark and China last week. The combined 650 jobs represent 1.5% of the 42,682 employees in 79 countries that Novo Nordisk said it employed at the end of last year, according to its Annual Report 2017 . “[Novo Nordisk] is ensuring the company is positioned to achieve long-term, sustainable growth in the face of pricing and competitive pressures in the US. Equally important is our need to invest in our current and ...
Original Article: Novo Nordisk Cutting 250 More Jobs, This Time in U.S.NEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...